Citation Impact
Citing Papers
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma
2009
Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation
2009
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
2014 Standout
Efficacy of beta 2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis
1997
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Transient MEK inhibitor-associated retinopathy in metastatic melanoma
2014
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
2009
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Diagnosis and Management of Bronchiolitis
2006
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Efficacy of Bronchodilator Therapy in Bronchiolitis
1996
The effects of a cold-water stimulus on butorphanol effects in males and females
2004
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Endogenous opiates: 1999
2000
Bronchodilators for bronchiolitis
1999
Delivery technologies for cancer immunotherapy
2019 Standout
Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: A propensity score−matched Surveillance, Epidemiology, and End Results analysis
2013
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
2019
Gene therapy in pancreatic cancer
2014
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
2013
Rexin-G, a targeted genetic medicine for cancer
2010
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
A Review of Novel Therapies for Melanoma
2014
Prospects for MEK inhibitors for treating cancer
2014
Gallbladder cancer: epidemiology and outcome
2014 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
MEK Inhibition in the Treatment of Advanced Melanoma
2013
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Gene Therapy for Pancreatic Diseases: Current Status
2018
Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer
2011
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Bronchodilators for bronchiolitis
2014
Short acting beta2-agonists for recurrent wheeze in children under two years of age
2002
Works of Fernando Quevedo being referenced
Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer
2008
Adjuvant Therapy for Gallbladder Carcinoma: The Mayo Clinic Experience
2009
Morphine-Induced Ventilatory Failure After Spinal Cord Compression
1999
Use of nebulized bronchodilators in infants under 1 year of age: Analysis of four forms of therapy
1987
Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle‐invasive bladder cancer treated with cisplatin‐based neoadjuvant chemotherapy and radical cystectomy: a single‐centre experience
2019
Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM).
2013
A phase I study of the raf kinase/VEGF-R inhibitor sorafenib in combination with bortezomib in patients with advanced malignancy
2008